Authors
Meghan Herring, Kimberly Groover, and Khaila Prather, Abt Global; Ashley L. Fowlkes, Kimberly Nguyen, and Julie Mayo Lamberte, Centers for Disease Control and Prevention; Karen Lutrick, Patrick Rivers, and Joel Parker, College of Medicine, University of Arizona; Zoe Baccam, College of Public Health, University of Arizona; Holly Groom and Allison L. Naleway, Center for Health Research, Kaiser Permanente Northwest; Manjusha Gaglani and Kayan Dunnigan, Texas A&M University College of Medicine; Andrew Phillips, Matthew S. Thiese, and Sarang Yoon, School of Medicine, University of Utah; Harmony Tyner, St. Luke’s Hospital, Duluth, MN
A study of essential workers found that COVID-19 vaccine knowledge, attitudes, and practices (KAP) responses predicted vaccine uptake and that perceptions of the COVID-19 vaccine can improve over time. Targeting messages about vaccine safety and effectiveness thus may increase vaccine uptake for reluctant and reachable participants.
Two surveys assessed a multi-center group of 4,803 essential workers who participate in the HEROES-RECOVER COVID-9 data-analysis projects. The surveys, three months apart, captured vaccine intention, prior SARS-CoV-2 positivity, and occupation, and their impact on vaccine uptake over time.
The first survey in December 2020 categorized participants as reluctant, reachable, or endorsers. Most (70%) were vaccine endorsers, 16% were reachable, and 14% were reluctant. By May 2021, 77% had received at least one vaccine dose. KAP responses strongly predicted vaccine uptake, particularly positive attitudes about safety and effectiveness. Participants with prior SARS-CoV-2 infection were 22% less likely to believe the COVID-19 vaccine was effective compared with uninfected participants and first responders were 42% less likely to believe in COVID-19 vaccine effectiveness.
In the second survey, reluctant and reachable participants’ positive scores modestly increased for perceived vaccine effectiveness (7% and 12%, respectively); 25% of initially reluctant participants received the COVID-19 vaccine.
Read More
COVID-19 in North America
APPAM Fall Research Conference 2026
Abt is a Gold Sponsor of APPAM 2026. Catch us in Boston, in our sessions and at booth 304, or connect with the team here!
National Association of Medicaid Directors (NAMD) Fall Conference 2026
Abt Global is a Sapphire sponsor of the NAMD 2026 Fall Conference. Find our Medicaid policy and data team at Booth 122.
Advancing Whole-Person Health: Implementing and Monitoring the MAHA ELEVATE Model
Abt supports CMS in implementing and monitoring the MAHA ELEVATE Model to build evidence on functional and lifestyle medicine approaches to manage and improve chronic disease for Original Medicare beneficiaries.
With Win, Abt Global Extends Support for USACE Navigation Data Mission
Abt wins a seat on a USACE IDIQ supporting the data and analytics behind lock monitoring, dredging, and U.S. waterway statistics.